CIAFFAGLIONE, VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 403
EU - Europa 281
AS - Asia 115
AF - Africa 34
SA - Sud America 22
OC - Oceania 1
Totale 856
Nazione #
US - Stati Uniti d'America 398
IT - Italia 190
SG - Singapore 73
IE - Irlanda 33
CN - Cina 29
CI - Costa d'Avorio 26
DE - Germania 21
BR - Brasile 20
FR - Francia 8
RU - Federazione Russa 8
SN - Senegal 6
KR - Corea 5
CA - Canada 4
ES - Italia 4
BD - Bangladesh 3
AR - Argentina 2
AT - Austria 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
GB - Regno Unito 2
KE - Kenya 2
NL - Olanda 2
UA - Ucraina 2
AL - Albania 1
AU - Australia 1
DO - Repubblica Dominicana 1
FI - Finlandia 1
HK - Hong Kong 1
IN - India 1
JO - Giordania 1
JP - Giappone 1
KZ - Kazakistan 1
LU - Lussemburgo 1
PL - Polonia 1
RO - Romania 1
Totale 856
Città #
Chandler 84
Santa Clara 71
Catania 50
Singapore 50
Dublin 33
Houston 32
Chicago 31
Ashburn 28
Abidjan 26
Boardman 19
Hefei 10
Naples 9
Bremen 8
Cambridge 8
Civitanova Marche 8
Andover 7
Lawrence 7
Redmond 7
Dakar 6
Los Angeles 6
Messina 6
Civitavecchia 5
Rome 5
Seoul 5
Aci Catena 4
Milan 4
Palermo 4
São Paulo 4
Wilmington 4
Foggia 3
Gela 3
New Haven 3
Pozzallo 3
Salerno 3
Scottsdale 3
The Dalles 3
Toronto 3
Viagrande 3
Washington 3
Boydton 2
Brno 2
Cagliari 2
Columbus 2
Council Bluffs 2
Dhaka 2
Ferrara di Monte Baldo 2
Froges 2
Garbagnate Milanese 2
Hebei 2
Ludwigshafen 2
Madrid 2
Marseille 2
Moscow 2
Nairobi 2
Nanjing 2
Seattle 2
Villamagna 2
Acireale 1
Amman 1
Atripalda 1
Aubervilliers 1
Augusta 1
Beijing 1
Bucharest 1
Calatabiano 1
Campinas 1
Canberra 1
Canoas 1
Castelvetrano 1
Caucete 1
Central 1
Chennai 1
Dallas 1
Des Moines 1
Dongyang 1
Esslingen am Neckar 1
Feira de Santana 1
Ferrara 1
Fier 1
Formiga 1
Gravina di Catania 1
Groningen 1
Guarulhos 1
Gunzenhausen 1
Hixson 1
Hwang Chow 1
Iturama 1
Jandira 1
Jinzhong 1
Jucás 1
Juneau 1
Kittanning 1
Kostanay 1
Lappeenranta 1
Latina 1
Leawood 1
London 1
Luxembourg 1
Modica 1
Morón 1
Totale 650
Nome #
Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application 114
Combination of heme oxygenase-1 inhibition and sigma receptor modulation for anticancer activity 107
Synthesis of “no-light activated” Ciprofloxacin and Norfloxacin derivatives as potential biofilm dispersant agents 89
New arylethanolimidazole derivatives as HO-1 inhibitors with cytotoxicity against MCF-7 breast cancer cells 85
Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors 74
Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia 70
Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary in vitro evaluation 66
Mutual Prodrugs of 5-Fluorouracil: From a Classic Chemotherapeutic Agent to Novel Potential Anticancer Drugs 66
Structure-activity relationships of mixed σ1R/σ2R ligands with antiproliferative and anticancer effects 57
Combination of heme oxygenase-1 inhibitors and temozolomide to improve the anticancer effect in glioblastoma 52
Copper(II) Complexes with Carnosine Conjugates of Hyaluronic Acids at Different Dipeptide Loading Percentages Behave as Multiple SOD Mimics and Stimulate Nrf2 Translocation and Antioxidant Response in In Vitro Inflammatory Model 42
Modulation of heme oxygenase-1 activity by novel synthetic compounds for pharmacological applications 33
Novel Heme Oxygenase-1 Inducers Palliate Inflammatory Pain and Emotional Disorders by Regulating NLRP3 Inflammasome and Activating the Antioxidant Pathway 29
Totale 884
Categoria #
all - tutte 3.220
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.220


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202126 0 3 3 2 7 0 2 2 0 2 4 1
2021/202298 11 13 14 6 13 2 11 5 4 3 1 15
2022/2023203 21 17 23 26 18 23 4 23 33 3 12 0
2023/2024112 2 9 5 10 16 33 0 5 6 3 12 11
2024/2025364 9 46 15 28 79 34 30 11 24 36 27 25
2025/202611 11 0 0 0 0 0 0 0 0 0 0 0
Totale 884